Compounds > valproic acid

valproic acid and givinostat hydrochloride

valproic acid has been researched along with givinostat hydrochloride in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armeanu, S; Bitzer, M; Göttlicher, M; Gregor, M; Lauer, UM; Mascagni, P; Pathil, A; Venturelli, S; Weiss, TS1
Armeanu, S; Bitzer, M; Gregor, M; Lauer, UM; Mascagni, P; Pathil, A; Venturelli, S; Weiss, TS1
Dinarello, CA; Fossati, G; Furlan, A; Kassu, A; Mascagni, P; Matalon, S; Nold, MF; Palmer, BE1

Other Studies

3 other study(ies) available for valproic acid and givinostat hydrochloride

ArticleYear
Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.
    Journal of hepatology, 2005, Volume: 42, Issue:2

    Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Division; Cell Line, Tumor; Cells, Cultured; Enzyme Inhibitors; Hepatocytes; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Liver Neoplasms; Valproic Acid

2005
HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
    Hepatology (Baltimore, Md.), 2006, Volume: 43, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cells, Cultured; Drug Resistance, Neoplasm; Enzyme Inhibitors; Hepatocytes; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Glycoproteins; Oligonucleotide Array Sequence Analysis; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Up-Regulation; Valproic Acid

2006
The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro.
    Journal of acquired immune deficiency syndromes (1999), 2010, May-01, Volume: 54, Issue:1

    Topics: CCR5 Receptor Antagonists; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Histone Deacetylase Inhibitors; HIV Core Protein p24; HIV-1; Humans; Hydroxamic Acids; Monocytes; Receptors, CXCR4; Valproic Acid

2010